Abstract
PARP7 is an enzyme that catalyzes mono-ADP-ribosylation (MARylation), is a critical regulator of type I interferon signaling, and has emerged as an immune-oncology drug candidate. PARP7 is a labile protein that is regulated in a proteasome-dependent manner. Indeed, endogenous PARP7 levels are undetectable by western blot in most cells. Intriguingly, treatment of cells with orthosteric small molecule inhibitors of PARP7 can increase endogenous PARP7 protein to detectable levels. This characteristic of PARP7 inhibitors could potentially be exploited to assess target engagement—and thus cellular efficacy—of PARP7 inhibitors; however, no method exists to quantitatively monitor endogenous PARP7 levels in a high-throughput manner. In this protocol, we describe an assay using a split Nanoluciferase (NanoLuc) system for quantifying endogenous PARP7 protein levels and PARP7 inhibitor target engagement in cells in a 96-well plate format. We show that this assay can be used to quantify PARP7 protein levels under various cellular treatments and can assess cellular PARP7 inhibitor target engagement. We envision this split NanoLuc PARP7 assay can be used not only for evaluating the cellular efficacy of PARP7 inhibitors in a high-throughput manner but also for uncovering the mechanisms regulating PARP7 protein levels in cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gomez A, Bindesbøll C, Satheesh SV et al (2018) Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP/ARTD14) catalytic activity. Biochem J 475:3827–3846. https://doi.org/10.1042/bcj20180347
Ma Q, Baldwin KT, Renzelli AJ et al (2001) TCDD-Inducible Poly(ADP-ribose) Polymerase: A Novel Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Biochem Bioph Res Co 289:499–506. https://doi.org/10.1006/bbrc.2001.5987
MacPherson L, Tamblyn L, Rajendra S et al (2013) 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation. Nucleic Acids Res 41:1604–1621. https://doi.org/10.1093/nar/gks1337
Yamada T, Horimoto H, Kameyama T et al (2016) Constitutive aryl hydrocarbon receptor signaling constrains type I interferon–mediated antiviral innate defense. Nat Immunol 17:687–694. https://doi.org/10.1038/ni.3422
Gozgit JM, Vasbinder MM, Abo RP et al (2021) PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. Cancer Cell. https://doi.org/10.1016/j.ccell.2021.06.018
Grunewald ME, Shaban MG, Mackin SR et al (2020) Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression. J Virol 94:e01743–e01719. https://doi.org/10.1128/jvi.01743-19
Kamata T, Yang C-S, Melhuish TA et al (2021) Post-transcriptional regulation of PARP7 protein stability is controlled by androgen signaling. Cells 10:363. https://doi.org/10.3390/cells10020363
Lu AZ, Abo R, Ren Y et al (2019) Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation. Biochem Pharmacol 167:97–106. https://doi.org/10.1016/j.bcp.2019.05.007
Zhang L, Cao J, Dong L, Lin H (2020) TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis. Proc Natl Acad Sci U S A 117:13447–13456. https://doi.org/10.1073/pnas.1921815117
Sanderson DJ, Rodriguez KM, Bejan DS, et al (2022) Structurally distinct PARP7 inhibitors reveal new insights into the regulation of cytosolic nucleic acid-sensing by PARP7. Cell Chem Biol, in press
Schwinn MK, Machleidt T, Zimmerman K et al (2017) CRISPR-mediated tagging of endogenous proteins with a luminescent peptide. ACS Chem Biol 13:467–474. https://doi.org/10.1021/acschembio.7b00549
Kirby IT, Sanderson DJ, Cohen MS (2021) PASTA: PARP activity screening and inhibitor testing assay. Star Protoc 2:100344. https://doi.org/10.1016/j.xpro.2021.100344
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Duell, A.K., Sanderson, D.J., Cohen, M.S. (2023). Quantification of PARP7 Protein Levels and PARP7 Inhibitor Target Engagement in Cells Using a Split Nanoluciferase System. In: Tulin, A.V. (eds) Poly(ADP-Ribose) Polymerase. Methods in Molecular Biology, vol 2609. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2891-1_24
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2891-1_24
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2890-4
Online ISBN: 978-1-0716-2891-1
eBook Packages: Springer Protocols